Chris A Rallis insider trades: Fennec Pharmaceuticals (FENC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Chris reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | FENC | ↓ Sell | 8,346 | $7.04 | $59K | Direct | May 12, 2026 (1d) |
| Oct 10, 2025 | FENC | ↓ Sell | 1,775 | $9.24 | $16K | Direct | Oct 14, 2025 (4d) |
| Jul 7, 2025 | FENC | ↓ Sell | 1,119 | $8.71 | $10K | Direct | Jul 7, 2025 (0d) |
| Apr 11, 2025 | FENC | ↓ Sell | 1,409 | $4.95 | $7K | Direct | Apr 11, 2025 (0d) |
| Feb 14, 2025 | FENC | ↓ Sell | 1,186 | $6.82 | $8K | Direct | Feb 14, 2025 (0d) |
| Dec 2, 2024 | FENC | ↓ Sell | 6,409 | $6.14 | $39K | Direct | Dec 2, 2024 (0d) |
| Oct 8, 2024 | FENC | ↓ Sell | 1,406 | $4.53 | $6K | Direct | Oct 10, 2024 (2d) |
| Jul 5, 2024 | FENC | ↓ Sell | 1,173 | $6.03 | $7K | Direct | Jul 8, 2024 (3d) |
| Apr 15, 2024 | FENC | ↓ Sell | 800 | $10.45 | $8K | Direct | Apr 15, 2024 (0d) |
| Mar 26, 2024 | FENC | ↓ Sell | 2,114 | $10.97 | $23K | Direct | Mar 27, 2024 (1d) |
| Dec 26, 2023 | FENC | ↓ Sell | 1,390 | $10.90 | $15K | Direct | Dec 28, 2023 (2d) |
| Nov 20, 2023 | FENC | ↓ Sell | 269 | $8.25 | $2K | Direct | Nov 20, 2023 (0d) |
| Aug 18, 2023 | FENC | ↓ Sell | 673 | $7.85 | $5K | Direct | Aug 18, 2023 (0d) |
| Jul 24, 2023 | FENC | ↓ Sell | 6,796 | $8.17 | $56K | Direct | Jul 24, 2023 (0d) |
| Jul 6, 2023 | FENC | ↓ Sell | 2,207 | $8.47 | $19K | Direct | Jul 6, 2023 (0d) |
| May 19, 2023 | FENC | ↓ Sell10b5-1 | 1,758 | $7.36 | $13K | Direct | May 19, 2023 (0d) |
| Nov 17, 2022 | FENC | ↓ Sell | 333 | $7.99 | $3K | Direct | Nov 17, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FENC insiders
Open-market trades in the last 12 months
About Chris A Rallis's insider trades
Chris A Rallis is an insider at Fennec Pharmaceuticals (FENC). Since Nov 17, 2022, Chris has reported no open-market purchases and 17 sales worth $297K on SEC Form 4. In the last 12 months: 1 sale ($59K).
1 sale (4% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (28 filings), option exercises (19 filings), shares withheld for taxes (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FENC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.